Skip to main content
logo
Immunovia AB (publ) (STO:IMMNOV)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.2025
+0.0005 (0.25%)
Apr 24, 2026, 5:24 PM CET

Immunovia AB Revenue

In the year 2025, Immunovia AB had annual revenue of 685.00K SEK, down -26.42%. Immunovia AB had revenue of 354.00K in the quarter ending December 31, 2025, a decrease of -22.20%.

Revenue
685.00K
Revenue Growth
-26.42%
P/S Ratio
198.85
Revenue / Employee
52.69K
Employees
13
Market Cap
136.22M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025685.00K-246.00K-26.42%
Dec 31, 2024931.00K-644.00K-40.89%
Dec 31, 20231.58M430.00K37.55%
Dec 31, 20221.15M301.00K35.66%
Dec 31, 2021844.00K482.00K133.15%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Getinge AB34.09B
Swedish Orphan Biovitrum AB28.24B
Sectra AB3.52B
Camurus AB2.27B
Physitrack149.47M
Ortivus AB73.40M
IRLAB Therapeutics AB57.46M
Clinical Laserthermia Systems AB17.49M
Revenue Rankings

Immunovia AB News

More News